MICHAEL RAAB - 21 Sep 2021 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
Director
Signature
/s/ Pierre Lorenzo (Attorney-in-Fact)
Issuer symbol
TPST
Transactions as of
21 Sep 2021
Net transactions value
$0
Form type
4
Filing time
23 Sep 2021, 19:56:05 UTC
Previous filing
24 Aug 2021
Next filing
29 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPST Stock Option (Right to Buy) Award $0 +6,635 $0.000000 6,635 21 Sep 2021 Common Stock 6,635 $15.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests over three (3) years, with one-third (1/3) of the award vesting on July 1, 2022 and the remainder of the award vesting in equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.